Massachusetts General Hospital is launching Boston’s second hand transplant program, hoping eventually to pioneer a new way of replacing patients’ limbs without subjecting them to a lifetime of dangerous antirejection drugs - an advance that could turn a rare operation into a routine one. Curtis Cetrulo, MGH Instructor in Surgery, Peter Slavin, MGH CEO, and Michael Zinner, head of the department of Surgery at Brigham and Women’s Hospital, are quoted.
